Literature DB >> 17493199

Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women.

Matthew J Delmonico1, Tamara B Harris, Jung-Sun Lee, Marjolein Visser, Michael Nevitt, Stephen B Kritchevsky, Frances A Tylavsky, Anne B Newman.   

Abstract

OBJECTIVES: To compare two methods for classifying an individual as sarcopenic for predicting decline in physical function in the Health, Aging and Body Composition Study.
DESIGN: Observational cohort study with 5 years of follow-up.
SETTING: Communities in Memphis, Tennessee, and Pittsburgh, Pennsylvania. PARTICIPANTS: Men and women aged 70 to 79 (N=2,976, 52% women, 41% black). MEASUREMENTS: Appendicular lean mass (aLM) was measured using dual energy x-ray absorptiometry, and participants were classified as sarcopenic first using aLM divided by height squared and then using aLM adjusted for height and body fat mass (residuals). Incidence of persistent lower extremity limitation (PLL) was measured according to self-report, and change in objective lower extremity performance (LEP) measures were observed using the Short Physical Performance Battery.
RESULTS: There was a greater risk of incident PLL in women who were sarcopenic using the residuals sarcopenia method than in women who were not sarcopenic (hazard ratio (HR)=1.34, 95% confidence interval (CI)=1.11-1.61) but not in men. Those defined as sarcopenic using the aLM/ht(2) method had lower incident PLL than nonsarcopenic men (HR=0.76, 95% CI=0.60-0.96) and women (HR=0.75, 95% CI=0.60-0.93), but these were no longer significant with adjustment for body fat mass. Using the residuals method, there were significantly poorer LEP scores in sarcopenic men and women at baseline and Year 6 and greater 5-year decline, whereas sarcopenic men defined using the aLM/ht(2) method had lower 5-year decline. Additional adjustment for fat mass attenuated this protective effect.
CONCLUSION: These findings suggest that sarcopenia defined using the residuals method, a method that considers height and fat mass together, is better for predicting disability in an individual than the aLM/ht(2) method, because it considers fat as part of the definition.

Entities:  

Mesh:

Year:  2007        PMID: 17493199     DOI: 10.1111/j.1532-5415.2007.01140.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  259 in total

1.  Sarcopenic indices in community-dwelling older adults.

Authors:  Ericka N Merriwether; Helen H Host; David R Sinacore
Journal:  J Geriatr Phys Ther       Date:  2012 Jul-Sep       Impact factor: 3.381

2.  Regional muscle and whole-body composition factors related to mobility in older individuals: a review.

Authors:  Jason Kidde; Robin Marcus; Lee Dibble; Sheldon Smith; Paul Lastayo
Journal:  Physiother Can       Date:  2009-11-12       Impact factor: 1.037

3.  Effect of moderate intensity resistance training during weight loss on body composition and physical performance in overweight older adults.

Authors:  Joshua J Avila; Julie A Gutierres; Megan E Sheehy; Ingrid E Lofgren; Matthew J Delmonico
Journal:  Eur J Appl Physiol       Date:  2010-02-19       Impact factor: 3.078

4.  Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

Authors:  W Kemmler; S von Stengel; K Engelke; C Sieber; E Freiberger
Journal:  Osteoporos Int       Date:  2015-08-29       Impact factor: 4.507

5.  Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study.

Authors:  Noriko Yoshimura; Shigeyuki Muraki; Toshiko Iidaka; Hiroyuki Oka; Chiaki Horii; Hiroshi Kawaguchi; Toru Akune; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Metab       Date:  2019-06-20       Impact factor: 2.626

6.  DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).

Authors:  B Vellas; R Fielding; R Miller; Y Rolland; S Bhasin; J Magaziner; H Bischoff-Ferrari
Journal:  J Frailty Aging       Date:  2014

7.  Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients.

Authors:  Yoshiyuki Morishita; Kazuya Kubo; Atushi Miki; Kenichi Ishibashi; Eiji Kusano; Daisuke Nagata
Journal:  Int Urol Nephrol       Date:  2014-02-13       Impact factor: 2.370

8.  Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study.

Authors:  D G Ohara; M S Pegorari; N L Oliveira Dos Santos; C de Fátima Ribeiro Silva; R L Monteiro; A P Matos; M Jamami
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 9.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review.

Authors:  Carmelo Messina; Gabriele Maffi; Jacopo Antonino Vitale; Fabio Massimo Ulivieri; Giuseppe Guglielmi; Luca Maria Sconfienza
Journal:  Quant Imaging Med Surg       Date:  2018-02

10.  Prostaglandin E2 induces transcription of skeletal muscle mass regulators interleukin-6 and muscle RING finger-1 in humans.

Authors:  R A Standley; S Z Liu; B Jemiolo; S W Trappe; T A Trappe
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-03-13       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.